ATRX mutation	Prostate Cancer	ATRX mutation	Prostate Cancer	olaparib Sensitive: C2 – Inclusion Criteria olaparib Sensitive : C2	olaparib Sensitive: C2 – Inclusion Criteria olaparib Sensitive : C2
ATRX mutation	Gastroesophageal Junction Adenocarcinoma	ATRX mutation	Gastroesophageal Junction Adenocarcinoma	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3
ATRX mutation	Gastric Adenocarcinoma	ATRX mutation	Gastric Adenocarcinoma	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3
ATRX mutation	Leiomyosarcoma	ATRX mutation	Leiomyosarcoma	eribulin mesylate Resistant: C3 – Early Trials eribulin mesylate Resistant : C3	eribulin mesylate Resistant: C3 – Early Trials eribulin mesylate Resistant : C3
ATRX mutation	Leiomyosarcoma	ATRX mutation	Leiomyosarcoma	dacarbazine Resistant: C3 – Early Trials dacarbazine Resistant : C3	dacarbazine Resistant: C3 – Early Trials dacarbazine Resistant : C3
ATRX mutation	Triple Negative Breast Cancer	ATRX mutation	Triple Negative Breast Cancer	olaparib Sensitive: C3 – Early Trials olaparib Sensitive : C3	olaparib Sensitive: C3 – Early Trials olaparib Sensitive : C3
ATRX mutation	Gastric Cancer	ATRX mutation	Gastric Cancer	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3
ATRX mutation	Neuroblastoma	ATRX mutation	Neuroblastoma	AZD1775 Sensitive: C3 – Early Trials AZD1775 Sensitive : C3	AZD1775 Sensitive: C3 – Early Trials AZD1775 Sensitive : C3
ATRX mutation + TP53 mutation + PTEN mutation	Pituitary Gland Carcinoma	ATRX mutation + TP53 mutation + PTEN mutation	Pituitary Gland Carcinoma	temozolomide Sensitive: C4 – Case Studies temozolomide Sensitive : C4	temozolomide Sensitive: C4 – Case Studies temozolomide Sensitive : C4
ATRX mutation	Glioblastoma	ATRX mutation	Glioblastoma	selumetinib Sensitive: D – Preclinical selumetinib Sensitive : D	selumetinib Sensitive: D – Preclinical selumetinib Sensitive : D
ATRX deletion	Glioma	ATRX deletion	Glioma	sunitinib + temozolomide Sensitive: D – Preclinical sunitinib + temozolomide Sensitive : D	sunitinib + temozolomide Sensitive: D – Preclinical sunitinib + temozolomide Sensitive : D
ATRX deletion	Glioma	ATRX deletion	Glioma	olaparib Sensitive: D – Preclinical olaparib Sensitive : D	olaparib Sensitive: D – Preclinical olaparib Sensitive : D

ATRX (ATRX Chromatin Remodeler)

Associations(15)

Associations
(15)